MARKET WIRE NEWS

Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)

Source: SeekingAlpha

2025-12-23 18:08:28 ET

The investment thesis I laid out in my first article about Teva Pharmaceutical ( TEVA ) has finally played out. At the time of that article, TEVA was fluctuating around $16.50-$17.00 and is now above $31.50. ...

Read the full article on Seeking Alpha

For further details see:

Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Alvotech Warrant

NASDAQ: ALVOW

ALVOW Trading

0.0% G/L:

$0.33 Last:

140 Volume:

$0.33 Open:

mwn-app Ad 300

ALVOW Latest News

ALVOW Stock Data

$1,551,281,147
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App